Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias Journal Article
| Authors: | Abdel-Wahab, O.; Manshouri, T.; Patel, J.; Harris, K.; Yao, J.; Hedvat, C.; Heguy, A.; Bueso-Ramos, C.; Kantarjian, H.; Levine, R. L.; Verstovsek, S. |
| Article Title: | Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias |
| Abstract: | The oncogenetic events that transform chronic myeloproliferative neoplasms (MPN) to acute myeloid leukemias (AML) are not well characterized. We investigated the role of several genes implicated in leukemic transformation by mutational analysis of 63 patients with AML secondary to a preexisting MPN (sAML). Frequent mutations were identified in TET2 (26.3%), ASXL1 (19.3%), IDH1 (9.5%), and JAK2 (36.8%) mutations in sAML, and all possible mutational combinations of these genes were also observed. Analysis of 14 patients for which paired samples from MPN and sAML were available showed that TET2 mutations were frequently acquired at leukemic transformation [6 of 14 (43%)]. In contrast, ASXL1 mutations were almost always detected in both the MPN and AML clones from individual patients. One case was also observed where TET2 and ASXL1 mutations were found before the patient acquired a JAK2 mutation or developed clinical evidence of MPN. We conclude that mutations in TET2, ASXL1, and IDH1 are common in sAML derived from a preexisting MPN. Although TET2/ASXL1 mutations may precede acquisition of JAK2 mutations by the MPN clone, mutations in TET2, but not ASXL1, are commonly acquired at the time of leukemic transformation. Our findings argue that the mutational order of events in MPN and sAML varies in different patients, and that TET2 and ASXL1 mutations have distinct roles in MPN pathogenesis and leukemic transformation. Given the presence of sAML that have no preexisting JAK2/TET2/ASXL1/IDH1 mutations, our work indicates the existence of other mutations yet to be identified that are necessary for leukemic transformation. ©2010 AACR. |
| Keywords: | myeloproliferative disorders; gene mutation; major clinical study; sequence analysis; single nucleotide polymorphism; mutation; dna-binding proteins; leukemia, myeloid, acute; proto-oncogene proteins; janus kinase 2; pathogenesis; genetic analysis; neoplasm; genotype; chronic myeloid leukemia; mutational analysis; cell transformation, neoplastic; molecular cloning; dna mutational analysis; repressor proteins; genetic polymorphism; isocitrate dehydrogenase; chronic myeloproliferative neoplasm |
| Journal Title: | Cancer Research |
| Volume: | 70 |
| Issue: | 2 |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2010-01-15 |
| Start Page: | 447 |
| End Page: | 452 |
| Language: | English |
| DOI: | 10.1158/0008-5472.can-09-3783 |
| PUBMED: | 20068184 |
| PROVIDER: | scopus |
| PMCID: | PMC2947340 |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 31" - "Export Date: 20 April 2011" - "CODEN: CNREA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work